<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NEWSTRON &#187; Biotech</title>
	<atom:link href="http://newstron.com/category/biotech/feed/" rel="self" type="application/rss+xml" />
	<link>http://newstron.com</link>
	<description>Global News &#38; Press Releases</description>
	<lastBuildDate>Tue, 21 Feb 2012 18:25:48 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pfizer To Market Biocon&#8217;s Insulin Products Globally</title>
		<link>http://newstron.com/pfizer-to-market-biocons-insulin-products-globally/</link>
		<comments>http://newstron.com/pfizer-to-market-biocons-insulin-products-globally/#comments</comments>
		<pubDate>Tue, 19 Oct 2010 21:45:48 +0000</pubDate>
		<dc:creator>NEWSTRON</dc:creator>
				<category><![CDATA[Americas]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[JVs]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Bangalore]]></category>
		<category><![CDATA[Biocon]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[Glargine]]></category>
		<category><![CDATA[glycemic control]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[Insulin Products]]></category>
		<category><![CDATA[Kiran Mazumdar-Shaw]]></category>
		<category><![CDATA[Murali Krishnan]]></category>
		<category><![CDATA[oral insulin clinical trials]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Recombinant Human Insulin]]></category>

		<guid isPermaLink="false">http://newstron.com/?p=207</guid>
		<description><![CDATA[October 19, 2010, Bangalore, India: Bangalore-based biotech company Biocon has entered into an agreement with Pfizer, the world&#8217;s biggest pharma company, under which the latter will pay $200 million (about Rs 900 crore) to have exclusive rights to commercialize several of Biocon&#8217;s insulin products globally.
Under the agreement, Biocon is also eligible to receive from Pfizer [...]]]></description>
		<wfw:commentRss>http://newstron.com/pfizer-to-market-biocons-insulin-products-globally/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Albert Einstein College of Medicine Receives $10.8 mn Grant to Develop Stem Cell based Therapies</title>
		<link>http://newstron.com/albert-einstein-college-of-medicine-receives-10-8-mn-grant-to-develop-stem-cell-based-therapies/</link>
		<comments>http://newstron.com/albert-einstein-college-of-medicine-receives-10-8-mn-grant-to-develop-stem-cell-based-therapies/#comments</comments>
		<pubDate>Wed, 11 Aug 2010 18:44:12 +0000</pubDate>
		<dc:creator>NEWSTRON</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[People]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[acute radiation syndrome]]></category>
		<category><![CDATA[Albert Einstein College of Medicine]]></category>
		<category><![CDATA[ARS]]></category>
		<category><![CDATA[brain research]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cardiac disease]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Chandan Guha]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[liver disease]]></category>
		<category><![CDATA[Lynne Hoppe]]></category>
		<category><![CDATA[Montefiore Medical Center]]></category>
		<category><![CDATA[neck cancer]]></category>
		<category><![CDATA[neuroscience]]></category>
		<category><![CDATA[radiation protection]]></category>
		<category><![CDATA[stem cell-based therapies]]></category>

		<guid isPermaLink="false">http://newstron.com/?p=188</guid>
		<description><![CDATA[Newswise — Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome – part of acute radiation syndrome (ARS) – for military personnel, first responders and the general public. The Einstein research, funded by [...]]]></description>
		<wfw:commentRss>http://newstron.com/albert-einstein-college-of-medicine-receives-10-8-mn-grant-to-develop-stem-cell-based-therapies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ecobrands Offers Free Trial For SagaPro -Herbal Remedy To Help Men With Overactive Bladders and Nocturia</title>
		<link>http://newstron.com/ecobrands-offers-free-trial-for-sagapro-herbal-remedy-to-help-men-with-overactive-bladders-and-nocturia/</link>
		<comments>http://newstron.com/ecobrands-offers-free-trial-for-sagapro-herbal-remedy-to-help-men-with-overactive-bladders-and-nocturia/#comments</comments>
		<pubDate>Fri, 08 Jan 2010 10:25:15 +0000</pubDate>
		<dc:creator>NEWSTRON</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Angelica herb]]></category>
		<category><![CDATA[benign prostatic hyperplasia]]></category>
		<category><![CDATA[BHP]]></category>
		<category><![CDATA[Bladder Control]]></category>
		<category><![CDATA[Ecobrands]]></category>
		<category><![CDATA[Iceland]]></category>
		<category><![CDATA[Nocturia]]></category>
		<category><![CDATA[SagaMedica]]></category>
		<category><![CDATA[SagaPro]]></category>
		<category><![CDATA[Voxis lozenges]]></category>

		<guid isPermaLink="false">http://newstron.com/?p=148</guid>
		<description><![CDATA[(Newstron) London, UK. January 8, 2010 &#8211; The wild Angelica herb which grows prolifically in Iceland &#8217;s volcanic uplands has been the source of medical remedies throughout the centuries since Viking times.

Modern herbal research by Icelandic scientist Prof. Gudbjarnason and others on the Angelica archangelica herb harvested in its wilderness habitat, has led to produce [...]]]></description>
		<wfw:commentRss>http://newstron.com/ecobrands-offers-free-trial-for-sagapro-herbal-remedy-to-help-men-with-overactive-bladders-and-nocturia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Calista Offers Affordable Ovulation Testing Kit with 98 Percent Accuracy</title>
		<link>http://newstron.com/calista-offers-affordable-ovulation-testing-kit-with-98-percent-accuracy/</link>
		<comments>http://newstron.com/calista-offers-affordable-ovulation-testing-kit-with-98-percent-accuracy/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 10:49:56 +0000</pubDate>
		<dc:creator>NEWSTRON</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Calista]]></category>
		<category><![CDATA[Ecobrands]]></category>
		<category><![CDATA[Ovulation Testing Kit]]></category>
		<category><![CDATA[saliva ovulation test]]></category>

		<guid isPermaLink="false">http://newstron.com/?p=114</guid>
		<description><![CDATA[(Newstron.com, November 17, 2009 ) London &#8211; Calista is a tried and tested saliva ovulation test used by many women all over the world.

A published clinical study at the University in Rome in 1994 tested 328 women and concluded that the mini-microscope demonstrated about 98 percent accuracy for women wanting to identify their likely fertile [...]]]></description>
		<wfw:commentRss>http://newstron.com/calista-offers-affordable-ovulation-testing-kit-with-98-percent-accuracy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Aquabalm Natural Skin Care Product Reports 1000 Satisfied Customers</title>
		<link>http://newstron.com/aquabalm-natural-skin-care-product-reports-1000-satisfied-customers/</link>
		<comments>http://newstron.com/aquabalm-natural-skin-care-product-reports-1000-satisfied-customers/#comments</comments>
		<pubDate>Thu, 01 Oct 2009 20:27:02 +0000</pubDate>
		<dc:creator>NEWSTRON</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Aquabalm]]></category>
		<category><![CDATA[arthritic inflammatory discomfort]]></category>
		<category><![CDATA[Gadus morhua]]></category>
		<category><![CDATA[natural marine enzymes]]></category>
		<category><![CDATA[Natural skin care]]></category>
		<category><![CDATA[Organic skin care]]></category>
		<category><![CDATA[Penzyme]]></category>

		<guid isPermaLink="false">http://newstron.com/?p=99</guid>
		<description><![CDATA[
London, September 30, 2009 – Aquabalm, a new skin care product from Iceland with revolutionary moisturizing technology derived from natural marine enzymes of the Arctic Ocean, reports 1,000 satisfied customers since its online launch earlier in 2009.
These satisfied customers come from diverse backgrounds worldwide, ranging from fashion models to teenagers to business executives, and they [...]]]></description>
		<wfw:commentRss>http://newstron.com/aquabalm-natural-skin-care-product-reports-1000-satisfied-customers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

